Patents by Inventor Inder KAUL

Inder KAUL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Medicament for therapeutic treatment and/or improvement of sepsis
    Patent number: 9592275
    Abstract: A medicament for therapeutic treatment and/or improvement of sepsis in a patient with severe sepsis accompanied with one or more organ dysfunctions, wherein a value of International Normalized Ratio (INR) of a plasma specimen obtained from said patient is more than 1.4, which comprises thrombomodulin as an active ingredient.
    Type: Grant
    Filed: November 14, 2012
    Date of Patent: March 14, 2017
    Assignee: ASAHI KASEI PHARMA CORPORATION
    Inventors: Kazuhisa Tsuruta, Yoshikazu Aoki, Yutaka Osawa, Inder Kaul
  • Medicament for therapeutic treatment and/or improvement of sepsis
    Patent number: 9555080
    Abstract: A medicament for therapeutic treatment and/or improvement of sepsis in a patient with severe sepsis accompanied with one or more organ dysfunctions, wherein a value of International Normalized Ratio (INR) of a plasma specimen obtained from said patient is more than 1.4, which comprises thrombomodulin as an active ingredient.
    Type: Grant
    Filed: August 2, 2016
    Date of Patent: January 31, 2017
    Assignee: Asahi Kasei Pharma Corporation
    Inventors: Kazuhisa Tsuruta, Yoshikazu Aoki, Yutaka Osawa, Inder Kaul
  • MEDICAMENT FOR THERAPEUTIC TREATMENT AND/OR IMPROVEMENT OF SEPSIS
    Publication number: 20160331813
    Abstract: A medicament for therapeutic treatment and/or improvement of sepsis in a patient with severe sepsis accompanied with one or more organ dysfunctions, wherein a value of International Normalized Ratio (INR) of a plasma specimen obtained from said patient is more than 1.4, which comprises thrombomodulin as an active ingredient.
    Type: Application
    Filed: August 2, 2016
    Publication date: November 17, 2016
    Applicant: ASAHI KASEI PHARMA CORPORATION
    Inventors: Kazuhisa TSURUTA, Yoshikazu AOKI, Yutaka OSAWA, Inder KAUL
  • MEDICAMENT FOR THERAPEUTIC TREATMENT AND/OR IMPROVEMENT OF SEPSIS
    Publication number: 20150157695
    Abstract: A medicament for therapeutic treatment and/or improvement of sepsis in a patient with severe sepsis accompanied with one or more organ dysfunctions, wherein a value of International Normalized Ratio (INR) of a plasma specimen obtained from said patient is more than 1.4, which comprises thrombomodulin as an active ingredient.
    Type: Application
    Filed: November 14, 2012
    Publication date: June 11, 2015
    Inventors: Kazuhisa Tsuruta, Yoshikazu Aoki, Yutaka Osawa, Inder Kaul
  • Medicament for therapeutic treatment and/or improvement of sepsis
    Patent number: 9034823
    Abstract: A medicament for therapeutic treatment and/or improvement of sepsis in a patient with severe sepsis accompanied with one or more organ dysfunctions, wherein a value of International Normalized Ratio (INR) of a plasma specimen obtained from said patient is more than 1.4, which comprises thrombomodulin as an active ingredient.
    Type: Grant
    Filed: May 21, 2014
    Date of Patent: May 19, 2015
    Assignee: ASAHI KASEI PHARMA CORPORATION
    Inventors: Kazuhisa Tsuruta, Yoshikazu Aoki, Yutaka Osawa, Inder Kaul
  • MEDICAMENT FOR THERAPEUTIC TREATMENT AND/OR IMPROVEMENT OF SEPSIS
    Publication number: 20140296148
    Abstract: A medicament for therapeutic treatment and/or improvement of sepsis in a patient with severe sepsis accompanied with one or more organ dysfunctions, wherein a value of International Normalized Ratio (INR) of a plasma specimen obtained from said patient is more than 1.4, which comprises thrombomodulin as an active ingredient.
    Type: Application
    Filed: May 21, 2014
    Publication date: October 2, 2014
    Inventors: Kazuhisa TSURUTA, Yoshikazu AOKI, Yutaka OSAWA, Inder KAUL
  • Medicament for therapeutic treatment and/or improvement of sepsis
    Patent number: 8772239
    Abstract: A medicament for therapeutic treatment and/or improvement of sepsis in a patient with severe sepsis accompanied with one or more organ dysfunctions, wherein a value of International Normalized Ratio (INR) of a plasma specimen obtained from said patient is more than 1.4, which comprises thrombomodulin as an active ingredient.
    Type: Grant
    Filed: November 14, 2012
    Date of Patent: July 8, 2014
    Assignee: Asahi Kasei Pharma Corporation
    Inventors: Kazuhisa Tsuruta, Yoshikazu Aoki, Yutaka Osawa, Inder Kaul
  • MEDICAMENT FOR THERAPEUTIC TREATMENT AND/OR IMPROVEMENT OF SEPSIS
    Publication number: 20130244926
    Abstract: A medicament for therapeutic treatment and/or improvement of sepsis in a patient with severe sepsis accompanied with one or more organ dysfunctions, wherein a value of International Normalized Ratio (INR) of a plasma specimen obtained from said patient is more than 1.4, which comprises thrombomodulin as an active ingredient.
    Type: Application
    Filed: May 17, 2013
    Publication date: September 19, 2013
    Applicant: ASAHI KASEI PHARMA CORPORATION
    Inventors: KAZUHISA TSURUTA, YOSHIKAZU AOKI, YUTAKA OSAWA, INDER KAUL
  • MEDICAMENT FOR THERAPEUTIC TREATMENT AND/OR IMPROVEMENT OF SEPSIS
    Publication number: 20130237482
    Abstract: A medicament for therapeutic treatment and/or improvement of sepsis in a patient with severe sepsis accompanied with one or more organ dysfunctions, wherein a value of International Normalized Ratio (INR) of a plasma specimen obtained from said patient is more than 1.4, which comprises thrombomodulin as an active ingredient.
    Type: Application
    Filed: November 14, 2012
    Publication date: September 12, 2013
    Applicant: ASAHI KASEI PHARMA CORPORATION
    Inventors: Kazuhisa TSURUTA, Yoshikazu AOKI, Yutaka OSAWA, Inder KAUL